The new asset will complement Lydall\'s existing global meltblown capacity and enable the company to supply the filtration media for an estimated one billion face masks per year.

"In the wake of Covid-19, the need for the filtration media that makes face masks effective has increased dramatically, so much so that it is now being called the 'golden fleece,'" said Sara Greenstein, president and CEO of Lydall. "As one of the only companies in North America and Europe with the technical expertise, supplier relationships and access to the right machines to produce this filtration media, we feel great responsibility to do everything within our power to increase our output, support domestic supply chains and contribute to the global fight against Covid-19. This investment is one example of Lydall\'s commitment to do just that."

Lydall expects commercial production to begin in Rochester during the fourth quarter of 2020. The company plans to hire up to 15 additional employees to support the increase in production.

In addition to manufacturing the critical filtration efficiency layers for N95 respirator masks, ASTM 1, 2, 3 medical masks, and general-purpose masks, Lydall also supplies other support materials for face masks, including comfort layers, protective layers and ties straps.

Lydall has also ramped up production of other filtration products like needlepunch felt for hospital gowns, medical wipes and absorbent bed pads. In preparation for the reopening of the US economy, Lydall\'s innovation team is working on developing new, high-efficiency, HEPA-rated filtration media to improve the air quality of public spaces, including office buildings, shopping centres, hospitals and airports.

For further information, visit <https://lydall.com/covid-19-relief-effort>
